Clarity Medical Group Holding Limited (the “Company”) (Stock Code: 1406) announced that a bankruptcy order was made against its former director, Mr. Tse Wai Ip, on 3 November 2025. This follows the Company’s earlier announcements regarding his vacation of office as an executive director on 1 August 2025 due to suspending payments or compounding with creditors. Under the bankruptcy order, Mr. Tse’s properties have vested in the Official Receiver in Hong Kong, and all of his creditors may submit a proof of debt for consideration.
Mr. Tse had initiated legal action against the Company under HCMP 1627/2025. According to legal advice cited in the announcement, causes of action not personal to Mr. Tse have vested in the Official Receiver or a future trustee in bankruptcy, rendering him unable to continue pursuing most parts of the action. The Company has instructed its legal advisers to contact the Official Receiver for next steps and will announce any significant developments as appropriate.
In a separate action (DCCJ 676/2025), Saintford Limited, a wholly-owned subsidiary of the Company, had sought to recover HK$1.75 million from Mr. Tse. Following his bankruptcy, creditors require the court’s permission to proceed with or commence legal actions for any debt provable in bankruptcy. The Company indicated it would submit proof of the debts owed by Mr. Tse to Saintford Limited with the Official Receiver in due course, though recovering the amount in full is unlikely.
The announcement concluded by noting that Mr. Tse’s bankruptcy does not materially impact the Company or its subsidiaries aside from the described legal proceedings. Debts owed by Mr. Tse to third parties outside the group remain unconnected to the Company, which bears no responsibility for such obligations.
Comments